Brenipatide
Sources
registry, as of 2026-07-16Stale
https://clinicaltrials.gov/study/NCT07476118
A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or Obesity. Overall status ACTIVE_NOT_RECRUITING. Phases PHASE1. Lead sponsor Eli Lilly and Company. Enrollment 150. Conditions Obesity; Overweight. The main purpose of this study is to evaluate how different dose levels of brenipatide work and how safe they are in healthy people with overweight or obesity. The study will assess the effects of different doses given as subcutaneous (under the skin) injections. Participation in
ClinicalTrials.gov NCT07476118 protocol and results modules